Product Information
CARBIDOPA-LEVO ER 50-200 TAB is a generic product labeled by Mylan Institutional LLC, priced at $0.1756 per EA under NDC 51079092320. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
50; 200 mg/1; mg/1
Manufacturer
Mylan Institutional LLCNDC
51079092320
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA075091On Market Since
12/1/1999
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVO ER 50-200 TAB has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 58.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1756 per EA |
|---|---|
| All-time high | $0.6666 (May 13, 2015) |
| All-time low | $0.1551 (May 22, 2024) |
| 52-week high | $0.2186 |
| 52-week low | $0.1756 |
| Median price | $0.3741 |
| Average price | $0.3493 |
| Largest weekly change | +52.4% (Jun 19, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVO ER 50-200 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO ER 50-200 TAB, manufactured by Mylan Institutional LLC, is $0.1756 per EA (NDC 51079092320), effective Jun 24, 2026.
How has the price of CARBIDOPA-LEVO ER 50-200 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has declined 58.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO ER 50-200 TAB?
Since Nov 28, 2013, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has ranged from a low of $0.1551 (May 22, 2024) to a high of $0.6666 (May 13, 2015), with a median of $0.3741 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVO ER 50-200 TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CARBIDOPA-LEVO ER 50-200 TAB, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVO ER 50-200 TAB?
CARBIDOPA-LEVO ER 50-200 TAB (NDC 51079092320) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification